期刊文献+

离心造粒法制备盐酸二甲双胍微丸的研究 被引量:3

Preparation of metformin hydrochloride pellets by using a centrifugal granulator
下载PDF
导出
摘要 目的:制备盐酸二甲双胍微丸。方法:采用离心造粒法制备盐酸二甲双胍微丸,分别对影响微丸粒径分布及收率的处方和工艺因素进行考察,并采用均匀设计法对成丸过程中影响收率的主要工艺因素进行优化。结果:主药与辅料的比例、黏合剂的浓度、主机转速和滚圆时间对微丸的粒径分布和收率有较显著的影响。喷浆和供粉速度是成丸过程中影响微丸收率的主要因素。结论:按优化后的处方及工艺采用离心造粒法制得18~24目微丸的收率为89.7%,且表面光滑,圆整度高。 OBJECTIVE To prepare rnetformin hydrochloride pellet. METHODS The metformin hydrochloride pellet was prepared by using a acentrifugal granulator. The influences of formulation and processing variables on the size distribution and yield of pellets were investigated. The optimal conditions of processing were selected by the uniform design. RESULTS The ratio of metformin hydrochloride to excipient, the concentration of the adhesive agent anti rotor rotation speed were found to have an significant influence on the size distribution and yield of pellets. The growth of pellets was affected significantly by the spraying rate of binder solution and feeding rate of powder. CONCLUSION Under the optimal formulation and processing variables, the pellets prepared by using the centrifugal granulator have perfect shape and surface characteristics and the yields of 1824 mesh pellets were 89.7%.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2006年第3期292-294,共3页 Chinese Journal of Hospital Pharmacy
关键词 离心造粒法 盐酸二甲双胍 制备 均匀设计法 centrifugal granulator metformin hydrochloride preparation uniform design
  • 相关文献

参考文献6

  • 1Dunn CJ,Peters DH.Metformin,a review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus[J].Drugs.1995,49(5):721-749.
  • 2Isaac Ghebre-Sellassie.Pharmaceutical Pelletization Technology [M].New York:Marcel Dekker Inc,1989,1-10.
  • 3Isaac Ghebre-Sellassie.Pharmaceutical Pelletization Technology[M].New York:Marcel Dekker Inc,1989,101-122.
  • 4Rashid Harun Ar,Heinamaki J,Antikainen O,et al.Effect of process variables on the size,shape,and surface charicteristics of microcrystalline cellulose beads prepared in a centrifugal granulator[J].Drug Dev Ind Pharm,1999,25 (5):605-611.
  • 5Isaac Ghebre-Sellassie.Pharmaceutical Pelletization Technology [M].New York:Marcel Dekker Inc,1989,167-175.
  • 6陈盛君,朱家壁.缓控释微丸制剂的研究进展[J].国外医学(药学分册),2004,31(3):177-181. 被引量:47

二级参考文献16

  • 1Mehta KA, Kislalioglu MS, Phuapradit W, et al. Release performance of a poorly soluble drug from a novel, Eudragit(R)based multi-unit erosion matrix [ J ]. Int J Pharm,2001, 213(1/2):7- 12.
  • 2Pillay V, Fassihi R. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. Ⅰ . Comparison of pH-responsive dmg release and associated kinetics[J]. J Control Release, 1999,59(2) :229 - 242.
  • 3Santos H, Veiga F, Pina M, et al. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables[J]. Int J Pharm, 2002, 246(1/2): 153 - 169.
  • 4Alvarez L, Concheiro A, Gomez-Amoza JL, et al. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug[J]. Eur J Pharm Biopharm, 20O3, 55(3) :291 - 295.
  • 5Tho I, Snade SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extruion/spheronisation[J]. Eur J Pharm Biopharm, 2003,56(3) :371 - 380.
  • 6Vergote GJ, Vervaet C, Van Driessche I, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen [ J]. Int J Pharm, 2001, 219(1/2): 81 - 87.
  • 7Satoshi U, Hisani Y, Masateru K, et al. Development of a novel drug release system, time-controlled explosion system (TES). Ⅱ .Design of multiparticulate TES and in vitro drug release properties [J]. Chem Pharm Bull, 1994, 42 (2):359- 363.
  • 8Ho HO, ChenCN, SheuMT. InfiuenceofpluronicF-68on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery[ J ]. J Control Release, 2000, 68(3):433-440.
  • 9Lecomte F, Siepmann J, Walther M, et al. Blends of enteric and GIT-insoluble polymers used for film coating:physicochemical characterization and drug release patterns[J]. J Control Release, 2003, 89(3):457-471.
  • 10Zheng W, McGinity JW. Influence of Eudragit(R)NE 30 D blended with Eudragit(R)L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets [ J]. Drug Dev Ind Pharm, 2003, 29(3):357-366.

共引文献46

同被引文献31

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部